The PROTACtable genome – a new route to drug discovery

Artist's impression of the proteasome targeting proteins for degradation. — Artist's impression of the proteasome targeting proteins for degradation. Credit: Karen Arnott/EMBL-EBI

Tags: Andrew Leach, drug discovery, drug targets, Industry, open access, Open Targets,

More Research highlights

Predicting cancer risk on the basis of national health data
23 May 2024

Breast tissue

‘Exhausted’ immune cells in healthy women could be target for breast cancer prevention
28 March 2024

Unravelling the role of immune cells in early lung development
20 December 2023

ggCaller: The next step in scaling up bacterial genome annotation
16 October 2023